Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Neutropenia in Cancer Patients

Neutropenia in Cancer Patients

en English

Complete this module today and earn yourself 1 CME Point.

Proceed to module  Shortlist  Rate Module  Share

en English


This module is based on the latest scientific evidence for neutropenia and the aim to improve outcomes for patients with neutropenia and reduce the risk of infection by providing recommendations based on current guidelines and best evidence.

This module was published on the 8th December 2017.

Target Audience

This education is aimed at consultants and/or attending physicians involved in the assessment, management and prevention of cancer-related Neutropenia.

Learning Objectives
  • To know the definition of febrile neutropenia in cancer patients.
  • Identify risk levels for the development and management of febrile neutropenia.
  • Understand the infectious etiologies of neutropenia.
  • Manage the consequences of febrile neutropenia, including preventive measures.
  • Educate patients to recognise signs and symptoms of potential infection during neutropenia.

This module awards the learner 1 CME point upon successful completion and passing of the assessment.

IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on HTML supported web browsers, however, can also run on FLASH enabled web browsers.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by an unrestricted grant from Amgen.

Disclosure Policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Amgen.

Proceed to Module

Relevant to the following professions

  • Oncologist
  • Other
Proceed to module  Shortlist  Rate Module

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation